Journal of BUON 期刊简介
JBUON aims at the rapid diffusion of scientific knowledge in Oncology.
Its character is multidisciplinary, therefore all aspects of oncologic activities are welcome including clinical research (medical oncology, radiation oncology, surgical oncology, nursing oncology, psycho-oncology, supportive care), as well as clinically-oriented basic and laboratory research, cancer epidemiology and social and ethical aspects of cancer. Experts of all these disciplines are included in the Editorial Board.
With a rapidly increasing body of new discoveries in clinical therapeutics, the molecular mechanisms that contribute to carcinogenesis, advancements in accurate and early diagnosis etc, JBUON offers a free forum for clinicians and basic researchers to make known promptly their achievements around the world.
With this aim JBUON accepts a broad spectrum of articles such as editorials, original articles, reviews, special articles, short communications, commentaries, letters to the editor and correspondence among authors and readers.
JBUON keeps the characteristics of its former paper print edition and appears as a bimonthly e-published journal with continuous volume, issue and page numbers.
JBUON旨在快速传播肿瘤学中的科学知识。
它的特点是多学科的,因此欢迎肿瘤活动的各个方面,包括临床研究 (医学肿瘤学,放射肿瘤学,外科肿瘤学,护理肿瘤学,心理肿瘤学,支持性护理),以及面向临床的基础和实验室研究,癌症流行病学以及癌症的社会和伦理方面。所有这些学科的专家都加入了编辑委员会。
随着临床治疗新发现的迅速增加,导致致癌的分子机制,准确和早期诊断的进步等,JBUON为临床医生和基础研究人员提供了一个免费的论坛,让他们迅速了解他们在世界各地的成就。
为此,JBUON接受了广泛的文章,如社论、原创文章、评论、特别文章、简短交流、评论、给编辑的信以及作者和读者之间的通信。
JBUON保留了其以前的纸质印刷版的特征,并以双月刊的形式出现,具有连续的数量,发行和页码。
期刊ISSN
|
1107-0625 |
影响指数
|
2.508 |
最新CiteScore值
|
2.30 查看CiteScore评价数据 |
最新自引率
|
21.40% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
ZERBINIS MEDICAL PUBL, 42 ANTIFILOU STR, ATHENS, GREECE, 157 71 |
偏重的研究方向(学科)
|
医学-肿瘤学 |
出版周期
|
Quarterly |
出版年份
|
199 |
出版国家/地区
|
GREECE |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)4区
否
|
|||||
最新的影响因子
|
2.508 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 22 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
2.30
|
||||||||||||||||||||||
年文章数 | 376 | ||||||||||||||||||||||
SJR
|
0.541 | ||||||||||||||||||||||
SNIP
|
0.577 | ||||||||||||||||||||||
CiteScore排名
|
|
||||||||||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
INTEGRATIVE CANCER THERAPIES | 3.246 |
Hormones & Cancer | 3.83 |
ENDOCRINE-RELATED CANCER | 5.621 |
Frontiers of Medicine | 4.546 |
Molecular Medicine Reports | 2.922 |
Molecular Therapy-Oncolytics | 7.128 |
American Journal of Translational Research | 4.019 |
BREAST | 4.336 |
Breast Care | 2.831 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
Molecular Medicine Reports | 2.922 |
Breast Care | 2.831 |
Breast Cancer | 4.197 |
Breast Journal | 2.407 |
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 0.194 |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 3.403 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2.632 |
Onkologe | 0.232 |
NEOPLASMA | 2.549 |
分享者 | 点评内容 |